| Serial Number | 79358602 |
| Word Mark | OMBLASTYS (131 I-OMBURTAMAB-YCWD) |
| Filing Date | Monday, October 17, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 2, 2024 |
| Registration Number | 7341739 |
| Registration Date | Tuesday, April 2, 2024 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, January 16, 2024 |
| Description of Mark | The mark consists of the wording "OMBLASTYS" and "(131 I-OMBURTAMAB-YCWD)". The word "OMBLASTYS" is in turquoise and appears in the middle of the figure mark. Below the word "OMBLASTYS" appears the second-word element "(131 I-OMBURTAMAB-YCWD)" in gray. In the top right corner of the mark just above "YS" in the word element "OMBLASTYS" a figure element appears. The shape element consists of three rhombuses right after each other at the top, where the first is in dark blue, and the one next to it is in dark green, and the next one next to it is in light green. Below these appear 5 triangles, the first, third and fifth are the same size, and the second and fourth are the same size but appear smaller than the first, third and fifth. The first triangle is in dark blue, and the second is also in dark blue. The third triangle is in the middle is turquoise. The penultimate fourth triangle is dark green. The last triangle is in green. The color white represents background, outlining, shading and/or transparent areas and are not part of the mark. |
| Goods and Services | Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; all of the aforesaid containing monoclonal antibodies |
| Pseudo Mark | OMBLASTYS ONE THREE ONE I OMBURTAMAB YCWD; OMBLASTYS ONE HUNDRED THIRTY ONE I OMBURTAMAB YCWD |
| Indication of Colors claimed | The colors turquoise, gray, dark blue, dark green, light green and green are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "131 I-OMBURTAMAB" |
| Goods and Services | Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of in the field of oncology, chemotherapy, and inflammatory diseases, namely antibodies; industrial analysis and research services in the field of chemistry, namely antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 30, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 30, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Y-mAbs Therapeutics, Inc |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | US |
| Party Name | Y-mAbs Therapeutics, Inc |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | US |
| Party Name | Y-mAbs Therapeutics, Inc |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | US |
| Event Date | Event Description |
| Tuesday, April 2, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 2, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 16, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 16, 2024 | PUBLISHED FOR OPPOSITION |
| Saturday, January 13, 2024 | NOTIFICATION PROCESSED BY IB |
| Wednesday, December 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 27, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, December 27, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Saturday, December 9, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 8, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, December 8, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, December 8, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 8, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, October 31, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, October 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, October 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, September 18, 2023 | REFUSAL PROCESSED BY IB |
| Thursday, August 31, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, August 31, 2023 | REFUSAL PROCESSED BY MPU |
| Friday, August 11, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, August 10, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 1, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, January 3, 2023 | APPLICATION FILING RECEIPT MAILED |
| Friday, December 30, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, December 28, 2022 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, December 23, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |